跳至主要内容
临床试验/NCT03367091
NCT03367091终止不适用

Energy Consumption and Cardiorespiratory Load During Overground Gait Training With a Wearable Exoskeleton After Stroke: the Effect of the Level of Swing Assistance

Vrije Universiteit Brussel1 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2018年7月9日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
1
试验地点
1
主要终点
Net oxygen cost (OC, ml/kg/m) at minute 10 of walking

研究概览

简要总结

To investigate acute metabolic and cardiorespiratory responses during overground gait training with a wearable exoskeleton in persons after stroke

详细描述

RESEARCH AIMS:

  • To investigate the effect of the level of swing assistance on the acute metabolic and cardiorespiratory responses during overground gait training with a wearable exoskeleton in persons after stroke
  • To investigate if there is an interaction-effect between the level of swing assistance and the duration of walking
  • To compare the exercise intensity to aerobic training recommendations

STUDY DESIGN: An experimental, 1-group trial with randomized crossover design.

PATIENT RECRUITMENT: Participants will be recruited at the AZ Herentals (Herentals, Belgium).

LOCATION: The trial will be conducted at the REVAlution Center (Herentals, Belgium).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Included will be persons who
  • •Had a stroke
  • •Cannot walk independently or can walk independently on level ground, but still require help on stairs, slopes or uneven surfaces (FAC 0 - 4)
  • •Excluded will be persons who
  • •Can walk independently on level ground, stairs, slopes and uneven surfaces (FAC 5)
  • •Have musculoskeletal problems (other than stroke) affecting the ability to walk
  • •Have concurrent pulmonary diseases (e.g. asthma)
  • •Have unstable cardiovascular conditions
  • •Have concurrent neurological diseases (e.g. Parkinson's Disease)
  • •Have communicative and/or cognitive problems affecting the ability to understand or follow instructions
  • •Present contra-indications for using the Ekso GT (according to manufacturer's instructions)
  • •Severe concurrent medical diseases (infections, circulatory, heart or lung, pressure sores)
  • •Severe spasticity (Ashworth 4)
  • •Range of motion restrictions that would prevent a patient from achieving normal, reciprocal gait pattern, or would restrict a patient from completing normal sit-to-stand or stand-to-sit transitions
  • •Bilateral hip flexion < 110°
  • •Knee flexion contracture > 12°
  • •Inability to achieve 0° neutral angle dorsiflexion with knee flexion ≤ 12°
  • •Weight ≥ 100 kg
  • •Hip width < 35.8 cm or > 45.6 cm
  • •Upper leg length < 51 cm or > 61.4 cm
  • •Lower leg length < 48 cm or > 63.4 cm
  • •Upper leg length discrepancy > 0.5 inch (1.3 cm)
  • •Lower leg length discrepancy > 0.75 inch (1.9 cm)
  • •Unstable spine, unhealed limbs or pelvic fractures
  • •Unhealthy bone density
  • •Heterotopic ossification
  • •Significant contractures
  • •Elbows and shoulders are unable to support crutches, walker or cane
  • •Psychiatric or cognitive situations that may interfere with proper operation of the device

排除标准

  • 未提供

研究组 & 干预措施

Ekso GT gait training

Experimental

Participants will be measured during three Ekso GT gait trainings:

  • 20-minute Ekso GT gait training with high swing assistance
  • 20-minute Ekso GT gait training with neutral swing assistance
  • 20-minute Ekso GT gait training with high swing resistance.

Each training will be performed on a separate day in a randomized order (within one week and controlled for time of day).

干预措施: Ekso GT gait training with high swing assistance (Other)

Ekso GT gait training

Experimental

Participants will be measured during three Ekso GT gait trainings:

  • 20-minute Ekso GT gait training with high swing assistance
  • 20-minute Ekso GT gait training with neutral swing assistance
  • 20-minute Ekso GT gait training with high swing resistance.

Each training will be performed on a separate day in a randomized order (within one week and controlled for time of day).

干预措施: Ekso GT gait training with neutral swing assistance (Other)

Ekso GT gait training

Experimental

Participants will be measured during three Ekso GT gait trainings:

  • 20-minute Ekso GT gait training with high swing assistance
  • 20-minute Ekso GT gait training with neutral swing assistance
  • 20-minute Ekso GT gait training with high swing resistance.

Each training will be performed on a separate day in a randomized order (within one week and controlled for time of day).

干预措施: Ekso GT gait training with high swing resistance (Other)

结局指标

主要结局

Net oxygen cost (OC, ml/kg/m) at minute 10 of walking

时间窗: Minute 10 of 20-minute walking period

Net oxygen consumption (oxygen consumption (ml/kg/min) during walking minus during rest) divided by the walking speed (m/min)

Net heart rate (HR, beats/min) at minute 5 of walking

时间窗: Minute 5 of 20-minute walking period

Heart rate during walking (beats/min) minus resting heart rate

Net heart rate (HR, beats/min) at minute 10 of walking

时间窗: Minute 10 of 20-minute walking period

Heart rate during walking (beats/min) minus resting heart rate

Net minute ventilation (VE, L/min) at minute 15 of walking

时间窗: Minute 15 of 20-minute walking period

The amount of air in- or exhaled per minute (L/min) during walking minus during rest

Net oxygen cost (OC, ml/kg/m) at minute 5 of walking

时间窗: Minute 5 of 20-minute walking period

Net oxygen consumption (oxygen consumption (ml/kg/min) during walking minus during rest) divided by the walking speed (m/min)

Net oxygen cost (OC, ml/kg/m) at minute 15 of walking

时间窗: Minute 15 of 20-minute walking period

Net oxygen consumption (oxygen consumption (ml/kg/min) during walking minus during rest) divided by the walking speed (m/min)

Net minute ventilation (VE, L/min) at minute 5 of walking

时间窗: Minute 5 of 20-minute walking period

The amount of air in- or exhaled per minute (L/min) during walking minus during rest

Net oxygen cost (OC, ml/kg/m) at minute 20 of walking

时间窗: Minute 20 of 20-minute walking period

Net oxygen consumption (oxygen consumption (ml/kg/min) during walking minus during rest) divided by the walking speed (m/min)

Net heart rate (HR, beats/min) at minute 15 of walking

时间窗: Minute 15 of 20-minute walking period

Heart rate during walking (beats/min) minus resting heart rate

Net heart rate (HR, beats/min) at minute 20 of walking

时间窗: Minute 20 of 20-minute walking period

Heart rate during walking (beats/min) minus resting heart rate

Net minute ventilation (VE, L/min) at minute 10 of walking

时间窗: Minute 10 of 20-minute walking period

The amount of air in- or exhaled per minute (L/min) during walking minus during rest

Net minute ventilation (VE, L/min) at minute 20 of walking

时间窗: Minute 20 of 20-minute walking period

The amount of air in- or exhaled per minute (L/min) during walking minus during rest

次要结局

  • Net Rating of Perceived Exertion (RPE, 6-20) at minute 15 of walking(Minute 15 of 20-minute walking period)
  • Net Rating of Perceived Exertion (RPE, 6-20) at minute 5 of walking(Minute 5 of 20-minute walking period)
  • Percentage maximal heart rate (%HRmax) at minute 10 of walking(Minute 10 of 20-minute walking period)
  • Percentage heart rate reserve (%HRR) at minute 20 of walking(Minute 20 of 20-minute walking period)
  • Net Rating of Perceived Exertion (RPE, 6-20) at minute 10 of walking(Minute 10 of 20-minute walking period)
  • Net Rating of Perceived Exertion (RPE, 6-20) at minute 20 of walking(Minute 20 of 20-minute walking period)
  • Percentage maximal heart rate (%HRmax) at minute 20 of walking(Minute 20 of 20-minute walking period)
  • Metabolic Equivalent of Task (MET) at minute 10 of walking(Minute 10 of 20-minute walking period)
  • Percentage maximal heart rate (%HRmax) at minute 15 of walking(Minute 15 of 20-minute walking period)
  • Metabolic Equivalent of Task (MET) at minute 20 of walking(Minute 20 of 20-minute walking period)
  • Percentage heart rate reserve (%HRR) at minute 15 of walking(Minute 15 of 20-minute walking period)
  • Metabolic Equivalent of Task (MET) at minute 5 of walking(Minute 5 of 20-minute walking period)
  • Percentage maximal heart rate (%HRmax) at minute 5 of walking(Minute 5 of 20-minute walking period)
  • Percentage heart rate reserve (%HRR) at minute 5 of walking(Minute 5 of 20-minute walking period)
  • Percentage heart rate reserve (%HRR) at minute 10 of walking(Minute 10 of 20-minute walking period)
  • Metabolic Equivalent of Task (MET) at minute 15 of walking(Minute 15 of 20-minute walking period)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nina Lefeber

Doctoral Researcher

Vrije Universiteit Brussel

研究点 (1)

Loading locations...

相似试验